Chong Kun Dang Pharmaceutical (185750) — Strategic Asset Allocation Index
Chong Kun Dang Pharmaceutical (185750) has a Strategic Asset Allocation Index of 50.0% as of December 2022. Strategic assets (PP&E of ₩310.70 Billion plus long-term investments of ₩-) total ₩310.70 Billion, measured against net assets of ₩621.29 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See debt-free asset ratio of Chong Kun Dang Pharmaceutical to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Chong Kun Dang Pharmaceutical Strategic Asset Allocation Index (2016–2022)
This chart shows how Chong Kun Dang Pharmaceutical's Strategic Asset Allocation Index has evolved across 7 annual periods from 2016 to 2022. As of December 2022, the index stands at 50.0%, representing strategic assets of ₩310.70 Billion against net assets of ₩621.29 Billion KRW. For live market cap and overall valuation, see 185750 company net worth.
Annual Strategic Asset Allocation Index for Chong Kun Dang Pharmaceutical (2016–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Chong Kun Dang Pharmaceutical from 2016 to 2022, covering 7 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See Chong Kun Dang Pharmaceutical shareholders equity for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (KRW) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 50.0% | ₩310.70 Billion | ₩310.70 Billion | ₩- | ₩621.29 Billion | ▼ -2.8 pp |
| 2021 | 52.8% | ₩298.91 Billion | ₩298.91 Billion | ₩- | ₩565.81 Billion | ▲ +3.0 pp |
| 2020 | 49.8% | ₩274.65 Billion | ₩274.65 Billion | ₩- | ₩551.59 Billion | ▼ -10.9 pp |
| 2019 | 60.7% | ₩288.18 Billion | ₩263.09 Billion | ₩25.09 Billion | ₩474.95 Billion | ▼ -4.1 pp |
| 2018 | 64.7% | ₩278.94 Billion | ₩254.11 Billion | ₩24.83 Billion | ₩430.90 Billion | ▼ -2.3 pp |
| 2017 | 67.0% | ₩270.22 Billion | ₩252.38 Billion | ₩17.84 Billion | ₩403.29 Billion | ▼ -7.3 pp |
| 2016 | 74.3% | ₩263.19 Billion | ₩244.68 Billion | ₩18.51 Billion | ₩354.25 Billion | — |